These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16400829)

  • 1. Human immune studies in multiple sclerosis.
    Bar-Or A
    Adv Neurol; 2006; 98():91-109. PubMed ID: 16400829
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid antibodies in aquaporin-4 antibody positive central nervous system autoimmunity and multiple sclerosis.
    Sellner J; Kalluri SR; Cepok S; Hemmer B; Berthele A
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):271-2. PubMed ID: 21521293
    [No Abstract]   [Full Text] [Related]  

  • 3. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell trafficking in the central nervous system.
    Sallusto F; Impellizzieri D; Basso C; Laroni A; Uccelli A; Lanzavecchia A; Engelhardt B
    Immunol Rev; 2012 Jul; 248(1):216-27. PubMed ID: 22725964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature, nurture, and microbes: The development of multiple sclerosis.
    Wekerle H
    Acta Neurol Scand; 2017 Nov; 136 Suppl 201():22-25. PubMed ID: 29068487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.
    Aktas O; Kieseier B; Hartung HP
    Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.
    Mildner A; Mack M; Schmidt H; Brück W; Djukic M; Zabel MD; Hille A; Priller J; Prinz M
    Brain; 2009 Sep; 132(Pt 9):2487-500. PubMed ID: 19531531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBV in MS: guilty by association?
    Lünemann JD; Münz C
    Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system: a modified immune surveillance circuit?
    Romo-González T; Chavarría A; Pérez-H J
    Brain Behav Immun; 2012 Aug; 26(6):823-9. PubMed ID: 22310920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in autoimmunity and the nervous system.
    Selmi C; Barin JG; Rose NR
    J Autoimmun; 2016 Dec; 75():20-29. PubMed ID: 27545842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing links in multiple sclerosis etiology. A working connecting hypothesis.
    Soulillou JP
    Med Hypotheses; 2013 May; 80(5):509-16. PubMed ID: 23466062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Astrocytes in Multiple Sclerosis.
    Ponath G; Park C; Pitt D
    Front Immunol; 2018; 9():217. PubMed ID: 29515568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trafficking of lymphocytes into the CNS.
    Schwab N; Schneider-Hohendorf T; Wiendl H
    Oncotarget; 2015 Jul; 6(20):17863-4. PubMed ID: 26255669
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the blood-brain barrier in multiple sclerosis.
    Ortiz GG; Pacheco-Moisés FP; Macías-Islas MÁ; Flores-Alvarado LJ; Mireles-Ramírez MA; González-Renovato ED; Hernández-Navarro VE; Sánchez-López AL; Alatorre-Jiménez MA
    Arch Med Res; 2014 Nov; 45(8):687-97. PubMed ID: 25431839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
    Hamid KM; Mirshafiey A
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):1-12. PubMed ID: 26996106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The virtues and vices of harnessing HSV vectors for CNS autoimmunity modulation.
    Hukkanen V; Nygårdas M
    Immunotherapy; 2013 Sep; 5(9):911-3. PubMed ID: 23998724
    [No Abstract]   [Full Text] [Related]  

  • 20. The best basic science paper in multiple sclerosis in 2014: important role for the choroid plexus in the central nervous system entry of leukocytes.
    Kooij G; de Vries HE
    Mult Scler; 2015 Apr; 21(4):372-3. PubMed ID: 25716882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.